NEWS
Mar 27, 2026

SSRP Institute Welcomes Medivive as New Trusted Partner

PARTNER ANNOUNCEMENT

WILLOUGHBY, Ohio, [March 27, 2026] — The SSRP Institute is pleased to announce that Medivive has joined its Trusted Partner Network following nomination and internal vetting aligned with SSRP’s mission of advancing science-first, education-driven clinical collaboration.

Medivive offers an advanced approach to NAD⁺ therapy designed to support cellular energetics through sterile, clinician-prescribed formulations produced under current Good Manufacturing Practices (cGMP) and dispensed by licensed pharmacies. Delivered subcutaneously, Medivive’s NAD⁺ therapy is designed to improve bioavailability compared to oral precursors while supporting tissue energy production and redox balance under medical supervision.

Jay Palmer, CEO and Co-Founder of Medivive says, "Dr. Seeds and I have known each other for a while, and when we started talking about what Medivive was building, the fit was obvious. SSRP practitioners hold their protocols to a high standard, and the Medivive pen was built to match it. This is the first prefilled NAD+ subcutaneous injector pen manufactured to cGMP standards at a 503B outsourcing facility in the US. Drug-grade testing on every batch, delivered the right way, with zero burden on the practice. We are proud to be the preferred NAD+ provider for this community." 

"Now, we can feel more confident in measuring and following the evidence on this with a safe product,” Dr. William Seeds, Founder and Academic Chairman of the SSRP Institute said recently on Episode 50 of his podcast, Redox Revolution. “This really opens the door to some powerful things you can start doing as you work to help that patient. I mean, it's things that I have not been able to do for a very long time.”

Certificates of Analysis covering potency, sterility, and endotoxin testing are maintained for every batch and are available to prescribers upon request. Medivive’s dedicated Partner Page is now live and provides SSRP Members with information about their offerings, research background, and ways they support clinical practice.

For more information and to view the Medivive Partner Page, visit:
SSRP Medivive Partner Page


About the SSRP Institute

The SSRP Institute is an education-focused organization dedicated to advancing cellular medicine through evidence-based training, professional collaboration, and clinically relevant research. SSRP supports providers worldwide through certifications, events, and ongoing educational programming designed to improve patient outcomes and elevate the standard of care.

The SSRP Trusted Partner Network is invitation-only and based on real-world clinical relevance, thoughtful nomination, and alignment with SSRP’s educational principles. Partners are integrated through a structured process designed to foster collaboration, support clinician education, and strengthen the implementation of cellular medicine practices.

RELATED RESOURCES

Continue exploring related topics.

VIEW ALL
VIDEO
Cellular Medicine Mondays
Jun 1, 2026
Ep. 090 - Dr. Seeds’ Office Hours - Bonus Episode
Preview Only
Dr. Seeds’ Office Hours – Episode 090

In this bonus episode from the MM15 Virtual Summit, Dr. Seeds addresses an important question around the use of GLP-1s for metabolic balancing in patients who do not need to lose weight. He shares his perspective on what may be considered microdosing, along with the clinical thought process he uses when determining appropriate dosing in these more nuanced cases.

Additional questions from the MM15 Virtual Summit can be found in our accompanying article here: [insert article link]

Access the full MM15 Course here: Mastermind 15 on Aesthetics

Preview Only — Become a member for full access
VIDEO
Cellular Medicine Mondays
May 25, 2026
Ep. 089 - The Limits of Alternative Peptide Delivery
Preview Only
Dissecting Protocols – Episode 089

The Limits of Alternative Peptide Delivery

Dr. Seeds reviews oral, sublingual, and transdermal peptide delivery, and explains why subcutaneous injection remains the gold standard for most peptides. (Question Link)

Preview Only — Become a member for full access
GuardianMD May 21, 2026
SSRP Institute Welcomes GuardianMD as New Trusted Partner
PARTNER ANNOUNCEMENT WILLOUGHBY, Ohio, [May 21, 2026] — The SSRP Institute announces that GuardianMD has joined its Trusted Partner Network following nomination and completion of the SSRP’s internal review process. GuardianMD is a healthcare services organization focused on physician collaboration and medical direction. It also provides telemedicine clearance services for healthcare practices. The company supports […]
READ NEWS
VIDEO
Cellular Medicine Mondays
May 18, 2026
Ep. 088 - A Deeper Look at the RAAS System
Preview Only
Rabbit Holes – Episode 088

A Deeper Look at the RAAS System

Dr. Seeds uses this Rabbit Holes episode to build on Journal Club Episode 87, revisiting the renin-angiotensin-aldosterone system and its broader role in cellular signaling. The discussion focuses on receptor balance, local tissue effects, and the mechanisms linking RAS disruption to inflammation, fibrosis, and mitochondrial stress.(Article Link)

Preview Only — Become a member for full access
ARTICLE
William Seeds, MD
May 14, 2026
How the Peptide AOD-9604 Targets LanCL Proteins to Fight Viral Infections and Neurodegenerative Conditions 
William Seeds, MD May 14, 2026
How the Peptide AOD-9604 Targets LanCL Proteins to Fight Viral Infections and Neurodegenerative Conditions 
In this research article, I return to the subject of my first-ever Journal Club (Ep. 017), in which I discussed a 2023 research study entitled, “Naturally derived cytokine peptides limit virus replication and severe disease during influenza A virus infection” (2023) that examined a specific growth hormone-derived peptide to address the underlying immunological mechanisms of post-viral […]
READ ARTICLE
VIDEO
Cellular Medicine Mondays
May 11, 2026
Ep. 087 - The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Cardiovascular Regulation
Preview Only
Journal Club – Episode 087

The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Cardiovascular Regulation

Dr. Seeds unpacks how RAS receptor balance drives inflammation, fibrosis, mitochondrial dysfunction, and tissue remodeling, far beyond its classical role in blood pressure regulation. (Article Link)

Preview Only — Become a member for full access
SSRP Institute May 6, 2026
Nutrition Education for Physicians and Medical Students
HEADLINE SCIENCE MAY 6, 2026 —Earlier in March, the U.S. Department of Health and Human Services (HHS) and the U.S. Department of Education announced an initiative to emphasize nutrition at the nation’s top medical schools. Reflecting U.S. Health and Human Services Secretary Robert Kennedy’s commitment to preventative medicine, this initiative will require “meaningful nutrition training” […]
READ NEWS
VIDEO
Cellular Medicine Mondays
May 4, 2026
Ep. 086 - May '26
Preview Only
SSRP Institute Apr 29, 2026
New ACC and AHA Cholesterol Management Guidelines
HEADLINE SCIENCE APRIL 29, 2026 – The American College of Cardiology (ACC) and American Heart Association (AHA) have updated their cholesterol management guidelines, advocating for earlier and more aggressive intervention based on the understanding that cumulative lifetime exposure to high LDL-C drives atherosclerotic cardiovascular disease (ASCVD) risk. The guidelines aim to standardize care for dyslipidemia […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Apr 27, 2026
Ep. 085 - Peptide Pharmacokinetics
Preview Only
Dissecting Protocols – Episode 085

Peptide Pharmacokinetics

Dissecting Protocols, Dr. Seeds breaks down the reasoning behind SubQ vs. IM peptide administration. From pharmacokinetic considerations to the growing misuse of combining peptides with oil-based medications in the same syringe, this discussion helps clarify proper application and safety considerations.

Preview Only — Become a member for full access

Subscribe to the SSRP Community Digest

Get the latest research and developments in the field of Cellular Medicine straight to your inbox every month.

This field is for validation purposes and should be left unchanged.